MESA LABORATORIES INC /CO/ MLAB

Technology SIC 3823 - Industrial Instruments For Measurement, Display, and Control NAICS Manufacturing › Computer and Electronic Product Manufacturing › Navigational, Measuring, Electromedical, and Control Instruments Manufacturing › Instruments and Related Products Manufacturing for Measuring, Displaying, and Controlling Industrial Process Variables derived Nasdaq

We are a global leader in the design and manufacture of life sciences tools and critical quality control solutions for regulated applications in the pharmaceutical, healthcare and medical device industries. We offer products and services to help our customers ensure product integrity, increase patient and worker safety, and improve the quality of life throughout the world. We have manufacturing operations in the United States and Europe, and our products are marketed by our sales personnel in North America, Europe and the Asia Pacific region ("APAC"), and by independent distributors throughout the world.

We are headquartered in Lakewood, Colorado and our common stock is listed for trading on the Nasdaq Global Market ("Nasdaq") under the symbol MLAB.

Last close 128.66 2026-10-23
Market cap $720.0M 2026-06-30 share count
52-week range 69.51 - 144.35

Valuation FY2025 figures against the last close

P/S2.9x
P/E106.3x
P/FCF18.2x
EV/EBITDA32.0x
Dividend yield0.5%
Diluted EPS1.21

Annual financial statements

Income statement

Fiscal year FY2025FY2024FY2023FY2022FY2021FY2020FY2019FY2018FY2017FY2016
Revenue $249.1M$241.0M$216.2M$219.1M$184.3M$133.9M$117.7M$103.1M$96.2M$93.7M
Cost of revenue $90.9M$90.1M$82.9M$85.4M$75.2M$46.9M$52.3M$42.2M$41.6M$40.4M
Gross profit $158.3M$150.9M$133.2M$133.7M$109.1M$87.0M$65.4M$60.9M$54.6M$53.2M
R&D $20.3M$19.5M$19.3M$20.5M$15.8M$10.4M$6.4M$3.5M$3.5M$4.2M
SG&A $78.7M$73.3M$72.9M$72.4M$60.3M$45.8M$38.2M$31.3M$26.3M$22.8M
Total operating expenses $139.8M$134.5M$405.3M$130.4M$104.4M$74.7M$57.4M$51.1M$52.4M$36.9M
Operating income $18.5M$16.3M-$272.1M$3.3M$4.7M$12.4M$7.9M$9.8M$2.2M$16.3M
Interest expense $10.7M$11.9M$5.7M$4.8M$3.9M$8.0M$5.5M$1.7M$1.9M—
Pre-tax income $12.0M$6.0M-$275.6M-$389.0K$3.6M$2.3M$3.9M$8.6M$301.0K$14.3M
Income tax $5.3M$7.9M$21.4M$1.3M$1.7M$971.0K$2.1M$1.1M$3.3M$3.1M
Net income $6.7M-$2.0M-$254.2M$930.0K$1.9M$3.3M————
EPS, basic 1.22-0.36-47.200.170.360.660.421.95-0.793.04
EPS, diluted 1.21-0.36-47.200.170.350.640.411.86-0.792.91
Shares, diluted (wtd. avg.) 5.6M5.4M5.4M5.4M5.3M5.1M4.4M4.0M3.8M3.8M

Balance sheet

Fiscal year FY2025FY2024FY2023FY2022FY2021FY2020FY2019FY2018FY2017FY2016
Cash and equivalents $26.9M$27.3M$28.2M$32.9M$49.3M$263.9M$81.4M$10.2M$5.5M$5.8M
Receivables $44.1M$42.0M$39.1M$42.6M$41.2M$23.8M$21.1M$12.5M$14.3M$14.3M
Inventory $26.4M$25.4M$32.7M$34.6M$24.6M$11.2M$14.2M$6.8M$9.2M$13.9M
Total current assets $106.3M$102.7M$109.4M$119.0M$124.3M$303.7M$122.8M$33.6M$32.0M$35.8M
Property, plant and equipment $30.6M$32.3M$31.8M$28.1M$28.6M$22.0M$22.1M$22.2M$23.6M$26.0M
Goodwill $186.9M$181.8M$180.1M$286.4M$291.2M$160.8M$141.5M$66.4M$65.5M$72.2M
Other intangibles $83.3M$96.9M$113.8M$216.8M$250.1M$111.7M$119.9M$33.2M$42.9M$37.8M
Total assets $427.7M$433.3M$446.8M$661.8M$707.4M$601.5M$409.1M$156.8M$164.1M$171.7M
Accounts payable $4.9M$5.7M$6.0M$6.1M$7.9M$4.5M$3.4M$2.9M$2.4M$2.2M
Short-term debt ———————$2.1M$1.6M$1.1M
Total current liabilities $61.9M$164.0M$44.3M$43.4M$48.1M$32.6M$26.0M$23.7M$17.3M$16.6M
Long-term debt $67.5M$71.2M—————$20.6M$44.6M$53.7M
Total liabilities $241.5M$273.5M$301.4M$268.4M$313.6M$195.2M$189.1M$45.5M$64.7M$73.9M
Retained earnings -$185.7M-$188.9M-$183.5M$74.2M$76.7M$72.5M$72.4M$73.3M$68.3M$73.7M
Total equity $186.2M$159.8M$145.4M$393.5M$393.8M$406.2M$220.0M$111.3M$99.4M$97.8M

Cash flow

Fiscal year FY2025FY2024FY2023FY2022FY2021FY2020FY2019FY2018FY2017FY2016
Operating cash flow $42.8M$46.8M$44.1M$28.0M$39.2M$37.1M$27.0M$30.6M$25.7M$17.3M
Depreciation and amortisation $5.3M$5.4M$4.2M$4.3M$3.3M$17.7M$13.0M$9.4M$9.5M$8.7M
Stock-based compensation $17.9M$13.1M$11.9M$12.5M$11.4M$9.3M$5.5M$4.2M$1.7M$1.4M
Capital expenditure $3.2M$4.2M$2.6M$4.5M$4.4M$2.0M$1.5M$1.3M$2.8M—
Investing cash flow -$3.2M-$4.5M-$81.3M-$9.5M-$305.2M-$2.0M-$185.6M-$3.9M-$17.2M-$18.4M
Financing cash flow -$41.9M-$44.5M$32.8M-$33.3M$52.6M$146.2M$231.3M-$21.7M-$9.0M$1.2M
Dividends paid $3.5M$3.5M$3.4M$3.4M$3.3M$3.2M$2.7M$2.5M$2.4M$2.4M

Figures as tagged in each year's own filing, in US dollars. A year restated by a later filing shows the restated figure. Capital expenditure, dividends and buybacks are cash out, shown positive. A line the filer does not report is not listed. Latest from accession 0000724004-26-000071.

Plot the figures US dollars

Income statement Revenue Cost of revenue Gross profit R&D SG&A Total operating expenses Operating income Interest expense Pre-tax income Income tax Net income EPS, basic EPS, diluted Shares, diluted (wtd. avg.)
Balance sheet Cash and equivalents Short-term investments Receivables Inventory Total current assets Property, plant and equipment Goodwill Other intangibles Total assets Accounts payable Short-term debt Total current liabilities Long-term debt Total liabilities Retained earnings Total equity
Cash flow Operating cash flow Depreciation and amortisation Stock-based compensation Capital expenditure Investing cash flow Financing cash flow Dividends paid Buybacks
  • Revenue
  • Gross profit
  • Net income
Revenue, Gross profit, Net income by fiscal year, in US dollars The same figures are in the table below this chart. -400M -200M 0 200M 400M Revenue, FY2016: 93.7M Gross profit, FY2016: 53.2M Revenue, FY2017: 96.2M Gross profit, FY2017: 54.6M Revenue, FY2018: 103.1M Gross profit, FY2018: 60.9M Revenue, FY2019: 117.7M Gross profit, FY2019: 65.4M Revenue, FY2020: 133.9M Gross profit, FY2020: 87M Net income, FY2020: 3.3M Revenue, FY2021: 184.3M Gross profit, FY2021: 109.1M Net income, FY2021: 1.9M Revenue, FY2022: 219.1M Gross profit, FY2022: 133.7M Net income, FY2022: 930K Revenue, FY2023: 216.2M Gross profit, FY2023: 133.2M Net income, FY2023: -254.2M Revenue, FY2024: 241M Gross profit, FY2024: 150.9M Net income, FY2024: -2M Revenue, FY2025: 249.1M Gross profit, FY2025: 158.3M Net income, FY2025: 6.7M FY2016 FY2017 FY2018 FY2019 FY2020 FY2021 FY2022 FY2023 FY2024 FY2025
Fiscal year FY2016FY2017FY2018FY2019FY2020FY2021FY2022FY2023FY2024FY2025
Revenue $93.7M $96.2M $103.1M $117.7M $133.9M $184.3M $219.1M $216.2M $241.0M $249.1M
Gross profit $53.2M $54.6M $60.9M $65.4M $87.0M $109.1M $133.7M $133.2M $150.9M $158.3M
Net income — — — — $3.3M $1.9M $930.0K -$254.2M -$2.0M $6.7M

Recent filings and events

  • Results announced The quarterly or annual earnings release. Arrives four times a year from almost every company here. Item 2.02
  • Code of ethics change The code of ethics changed, or somebody was excused from part of it. Item 5.05
  • Officer or director change Someone at the top arrived or left. The item covers everything from a board retirement to a chief executive being removed, and only the filing itself says which. Item 5.02
  • Annual report filed A new 10-K. The figures and the business description on this site come from it. Form 10-K
  • Results announced Item 2.02
  • Officer or director change Item 5.02
  • Officer or director change Item 5.02
  • Regulation FD disclosure Something the company told the market and had to tell everyone at once - usually a slide deck or a press release. Item 7.01
  • Results announced Item 2.02
  • Results announced Item 2.02
  • Shareholder vote The results of the annual meeting or a special vote. Item 5.07
  • New debt or obligation The company has taken on debt or a comparable obligation. Item 2.03

Item numbers are Form 8-K's own, and a filing date is up to four business days after the thing it reports. The same feed across the whole market.

Others in SIC 3823

TickerCompanyMarket capP/ERevenue growth
DHR DANAHER CORP /DE/ $162.04B 45.6x 2.9%
AME AMETEK INC/ $55.03B 37.5x 6.6%
KEYS Keysight Technologies, Inc. $53.59B 64.1x 8.0%
ROP ROPER TECHNOLOGIES INC $43.33B 30.9x 12.3%
FTV Fortive Corp $18.37B 34.8x 1.9%
MKSI MKS INC $13.29B 45.0x 9.6%
CGNX COGNEX CORP $9.34B 81.7x 8.7%
RAL Ralliant Corp $7.36B — -4.0%